Ratings by Stifel (Stephen Willey)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/23/2026 | Crescent Biopharma Inc | CBIO | Maintain | Buy (Buy) |
|
Details | ||
| 6/15/2026 | Syndax Pharmaceuticals | SNDX | Maintain | Buy (Buy) |
|
Details | ||
| 6/15/2026 | Nurix | NRIX | Maintain | Buy (Buy) |
|
Details | ||
| 6/15/2026 | Incyte | INCY | Maintain | Buy (Buy) |
|
Details | ||
| 6/9/2026 | Incyte | INCY | Maintain | Buy (Buy) |
|
Details | ||
| 6/3/2026 | Syndax Pharmaceuticals | SNDX | Maintain | Buy (Buy) |
|
Details | ||
| 6/3/2026 | Disc Medicine | IRON | Maintain | Buy (Buy) |
|
Details | ||
| 6/2/2026 | Celcuity Inc | CELC | Maintain | Buy (N/A) |
|
Details | ||
| 6/1/2026 | Incyte | INCY | Maintain | Buy (Buy) |
|
Details | ||
| 6/1/2026 | Compass Therapeutics | CMPX | Maintain | Buy (Buy) |
|
Details | ||
| 5/15/2026 | Celcuity Inc | CELC | Maintain | Buy (N/A) |
|
Details | ||
| 5/11/2026 | Bicara Therapeutics Inc | BCAX | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2026 | Exelixis | EXEL | Maintain | Hold (N/A) |
|
Details | ||
| 5/4/2026 | Syndax Pharmaceuticals | SNDX | Maintain | Buy (Buy) |
|
Details | ||
| 5/4/2026 | Celcuity Inc | CELC | Maintain | Buy (Buy) |
|
Details | ||
| 5/1/2026 | Syndax Pharmaceuticals | SNDX | Maintain | Buy (N/A) |
|
Details | ||
| 4/30/2026 | Crescent Biopharma Inc | CBIO | Maintain | Buy (N/A) |
|
Details | ||
| 4/29/2026 | Incyte | INCY | Maintain | Buy (Buy) |
|
Details | ||
| 4/27/2026 | Compass Therapeutics | CMPX | Maintain | Buy (N/A) |
|
Details | ||
| 4/27/2026 | Compass Therapeutics | CMPX | Maintain | Buy (N/A) |
|
Details | ||
| 4/22/2026 | Zymeworks | ZYME | Maintain | Buy (Buy) |
|
Details | ||
| 4/8/2026 | Nurix | NRIX | Maintain | Buy (N/A) |
|
Details | ||
| 4/8/2026 | Vor Biopharma, Inc. | VOR | Maintain | Buy (Buy) |
|
Details | ||
| 4/8/2026 | Insmed | INSM | Maintain | Buy (Buy) |
|
Details | ||
| 3/31/2026 | Compass Therapeutics | CMPX | Maintain | Buy (Buy) |
|
Details | ||
| 3/30/2026 | Vor Biopharma, Inc. | VOR | Maintain | Buy (N/A) |
|
Details | ||
| 3/30/2026 | Insmed | INSM | Maintain | Buy (N/A) |
|
Details | ||
| 3/30/2026 | Incyte | INCY | Maintain | Buy (Buy) |
|
Details | ||
| 3/30/2026 | Disc Medicine | IRON | Maintain | Buy (Buy) |
|
Details | ||
| 3/26/2026 | Nkarta Inc. | NKTX | Maintain | Buy (Buy) |
|
Details | ||
| 3/26/2026 | Celcuity Inc | CELC | Maintain | Buy (Buy) |
|
Details | ||
| 3/24/2026 | Insmed | INSM | Maintain | Buy (Buy) |
|
Details | ||
| 3/23/2026 | Insmed | INSM | Maintain | Buy (N/A) |
|
Details | ||
| 3/17/2026 | Abeona Therapeutics | ABEO | Maintain | Buy (N/A) |
|
Details | ||
| 3/10/2026 | MacroGenics | MGNX | Maintain | Hold (N/A) |
|
Details | ||
| 3/9/2026 | Incyte | INCY | Maintain | Buy (Buy) |
|
Details | ||
| 3/5/2026 | OmniAb, Inc. | OABI | Maintain | Buy (Buy) |
|
Details | ||
| 3/3/2026 | Zymeworks | ZYME | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2026 | Syndax Pharmaceuticals | SNDX | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2026 | Disc Medicine | IRON | Maintain | Buy (Buy) |
|
Details | ||
| 2/26/2026 | Crescent Biopharma Inc | CBIO | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2026 | Arcellx Inc. | ACLX | Downgrade | Hold (Buy) |
64.11 (115.07) |
79.49% | Details | |
| 2/19/2026 | Insmed | INSM | Maintain | Buy (N/A) |
|
Details | ||
| 2/17/2026 | Disc Medicine | IRON | Maintain | Buy (N/A) |
|
Details | ||
| 2/11/2026 | Incyte | INCY | Maintain | Buy (N/A) |
|
Details | ||
| 2/11/2026 | Exelixis | EXEL | Maintain | Hold (N/A) |
|
Details | ||
| 2/9/2026 | Arcellx Inc. | ACLX | Maintain | Buy (Buy) |
|
Details | ||
| 1/29/2026 | Nurix | NRIX | Maintain | Buy (N/A) |
|
Details | ||
| 1/12/2026 | Exelixis | EXEL | Maintain | Hold (Hold) |
|
Details | ||
| 1/6/2026 | Compass Therapeutics | CMPX | Maintain | Buy (N/A) |
|
Details | ||
| 1/5/2026 | Incyte | INCY | Maintain | Buy (N/A) |
|
Details | ||
| 12/19/2025 | Disc Medicine | IRON | Maintain | Buy (N/A) |
|
Details | ||
| 12/18/2025 | Insmed | INSM | Maintain | Buy (Buy) |
|
Details | ||
| 12/11/2025 | Exelixis | EXEL | Maintain | Hold (Hold) |
|
Details | ||
| 12/8/2025 | Nurix | NRIX | Maintain | Buy (Buy) |
|
Details | ||
| 12/8/2025 | Bicara Therapeutics Inc | BCAX | Maintain | Buy (Buy) |
|
Details | ||
| 12/4/2025 | Crescent Biopharma Inc | CBIO | Maintain | Buy (N/A) |
|
Details | ||
| 12/2/2025 | Janux Therapeutics | JANX | Maintain | Buy (N/A) |
|
Details | ||
| 11/25/2025 | Arcellx Inc. | ACLX | Maintain | Buy (Buy) |
|
Details | ||
| 11/19/2025 | Zymeworks | ZYME | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2025 | Celcuity Inc | CELC | Maintain | Buy (N/A) |
|
Details | ||
| 11/12/2025 | Abeona Therapeutics | ABEO | Maintain | Buy (N/A) |
|
Details | ||
| 11/11/2025 | Nkarta Inc. | NKTX | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2025 | Zymeworks | ZYME | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2025 | Janux Therapeutics | JANX | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2025 | Celsius Holdings | CELH | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2025 | X4 Pharmaceuticals | XFOR | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2025 | OmniAb, Inc. | OABI | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2025 | Exelixis | EXEL | Maintain | Hold (N/A) |
|
Details | ||
| 11/4/2025 | Syndax Pharmaceuticals | SNDX | Maintain | Buy (Buy) |
|
Details | ||
| 11/3/2025 | Disc Medicine | IRON | New Coverage | Buy (N/A) |
86.22 (71.47) |
-17.11% | Details | |
| 10/27/2025 | Syndax Pharmaceuticals | SNDX | Maintain | Buy (Buy) |
|
Details | ||
| 10/24/2025 | Celsius Holdings | CELH | Maintain | Buy (N/A) |
|
Details | ||
| 10/21/2025 | Bicara Therapeutics Inc | BCAX | Maintain | Buy (Buy) |
|
Details | ||
| 10/16/2025 | Arcellx Inc. | ACLX | New Coverage | Buy (N/A) |
87.33 (64.11) |
-26.59% | Details | |
| 10/10/2025 | Nurix | NRIX | Maintain | Buy (N/A) |
|
Details | ||
| 9/24/2025 | Vor Biopharma, Inc. | VOR | Upgrade | Buy (Hold) |
27.94 (14.81) |
-46.99% | Details | |
| 9/22/2025 | Incyte | INCY | Maintain | Buy (N/A) |
|
Details | ||
| 9/18/2025 | Nurix | NRIX | Maintain | Buy (Buy) |
|
Details | ||
| 9/10/2025 | Janux Therapeutics | JANX | New Coverage | Buy (N/A) |
24.81 (15.01) |
-39.5% | Details | |
| 9/10/2025 | Syndax Pharmaceuticals | SNDX | New Coverage | Buy (N/A) |
16.33 (20.31) |
24.37% | Details | |
| 9/2/2025 | Celsius Holdings | CELH | Maintain | Buy (N/A) |
|
Details | ||
| 8/29/2025 | X4 Pharmaceuticals | XFOR | Maintain | Buy (N/A) |
|
Details | ||
| 8/27/2025 | Crescent Biopharma Inc | CBIO | Maintain | Buy (Buy) |
|
Details | ||
| 8/15/2025 | Celcuity Inc | CELC | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2025 | Nkarta Inc. | NKTX | Maintain | Buy (Buy) |
|
Details | ||
| 8/14/2025 | Nkarta Inc. | NKTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2025 | Insmed | INSM | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2025 | Celsius Holdings | CELH | Maintain | Buy (Buy) |
|
Details | ||
| 7/29/2025 | Exelixis | EXEL | Maintain | Hold (N/A) |
|
Details | ||
| 7/29/2025 | Celsius Holdings | CELH | Maintain | Buy (N/A) |
|
Details | ||
| 7/14/2025 | Compass Therapeutics | CMPX | Maintain | Buy (N/A) |
|
Details | ||
| 7/10/2025 | Nurix | NRIX | Maintain | Buy (Buy) |
|
Details | ||
| 7/10/2025 | Nurix | NRIX | Maintain | Buy (N/A) |
|
Details | ||
| 7/1/2025 | Celcuity Inc. | CELC | New Coverage | Buy (N/A) |
46.39 (96.50) |
108.02% | Details | |
| 6/26/2025 | Incyte | INCY | Maintain | Buy (N/A) |
|
Details | ||
| 6/26/2025 | Vor Biopharma, Inc. | VOR | Maintain | Hold (Hold) |
|
Details | ||
| 6/25/2025 | Catalyst Biosciences | CBIO | New Coverage | Buy (N/A) |
15.30 (17.79) |
16.27% | Details | |
| 6/23/2025 | Exelixis | EXEL | Maintain | Hold (Hold) |
|
Details | ||
| 6/16/2025 | Incyte | INCY | Upgrade | Buy (Hold) |
69.22 (108.43) |
56.65% | Details | |
| 6/11/2025 | MacroGenics | MGNX | Maintain | Hold (Hold) |
|
Details | ||
| 6/10/2025 | Insmed | INSM | Maintain | Buy (N/A) |
|
Details | ||
| 6/9/2025 | Bicara Therapeutics Inc | BCAX | Maintain | Buy (Buy) |
|
Details | ||
| 6/4/2025 | Incyte | INCY | Maintain | Hold (Hold) |
|
Details | ||
| 6/3/2025 | Exelixis | EXEL | Maintain | Hold (N/A) |
|
Details | ||
| 6/3/2025 | Zymeworks | ZYME | Maintain | Buy (Buy) |
|
Details | ||
| 6/3/2025 | Nurix | NRIX | Maintain | Buy (N/A) |
|
Details | ||
| 6/3/2025 | Zymeworks | ZYME | Maintain | Buy (N/A) |
|
Details | ||
| 6/2/2025 | Bicara Therapeutics Inc | BCAX | Maintain | Buy (Buy) |
|
Details | ||
| 5/23/2025 | Bicara Therapeutics Inc | BCAX | Maintain | Buy (Buy) |
|
Details | ||
| 5/16/2025 | Abeona Therapeutics | ABEO | Maintain | Buy (Buy) |
|
Details | ||
| 5/14/2025 | MacroGenics | MGNX | Maintain | Hold (N/A) |
|
Details | ||
| 5/14/2025 | Exelixis | EXEL | Maintain | Hold (N/A) |
|
Details | ||
| 5/8/2025 | Vor Biopharma, Inc. | VOR | Downgrade | Hold (Buy) |
0.54 (27.94) |
5074.07% | Details | |
| 4/30/2025 | Incyte | INCY | Maintain | Hold (Hold) |
|
Details | ||
| 4/29/2025 | Abeona Therapeutics | ABEO | Maintain | Buy (N/A) |
|
Details | ||
| 4/9/2025 | Nurix | NRIX | Maintain | Buy (Buy) |
|
Details | ||
| 4/9/2025 | Nurix | NRIX | Maintain | Buy (N/A) |
|
Details | ||
| 4/8/2025 | Abeona Therapeutics | ABEO | New Coverage | Buy (N/A) |
4.51 (5.72) |
26.83% | Details | |
| 3/27/2025 | Bicara Therapeutics Inc | BCAX | Maintain | Buy (N/A) |
|
Details | ||
| 3/27/2025 | Nkarta Inc. | NKTX | Maintain | Buy (Buy) |
|
Details | ||
| 3/27/2025 | Nkarta Inc. | NKTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/26/2025 | Exelixis | EXEL | Maintain | Hold (N/A) |
|
Details | ||
| 3/25/2025 | X4 Pharmaceuticals | XFOR | Maintain | Buy (N/A) |
|
Details | ||
| 3/21/2025 | MacroGenics | MGNX | Maintain | Hold (Hold) |
|
Details | ||
| 3/21/2025 | Vor Biopharma, Inc. | VOR | Maintain | Buy (Buy) |
|
Details | ||
| 3/10/2025 | Compass Therapeutics | CMPX | Maintain | Buy (N/A) |
|
Details | ||
| 3/7/2025 | IGM Biosciences | IGMS | Maintain | Hold (Hold) |
|
Details | ||
| 3/6/2025 | Zymeworks | ZYME | Maintain | Buy (Buy) |
|
Details | ||
| 2/27/2025 | Geron Corporation | GERN | Maintain | Buy (N/A) |
|
Details | ||
| 2/12/2025 | Exelixis | EXEL | Maintain | Hold (Hold) |
|
Details | ||
| 2/12/2025 | Exelixis | EXEL | Maintain | Hold (N/A) |
|
Details | ||
| 2/10/2025 | Incyte | INCY | Maintain | Hold (N/A) |
|
Details | ||
| 1/29/2025 | Nurix | NRIX | Maintain | Buy (Buy) |
|
Details | ||
| 1/27/2025 | Exelixis | EXEL | Maintain | Hold (Hold) |
|
Details | ||
| 1/27/2025 | Bicara Therapeutics Inc | BCAX | Maintain | Buy (Buy) |
|
Details | ||
| 1/10/2025 | IGM Biosciences | IGMS | Downgrade | Hold (Buy) |
6.80 (1.27) |
-81.32% | Details | |
| 12/11/2024 | Geron Corporation | GERN | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2024 | X4 Pharmaceuticals | XFOR | Maintain | Buy (N/A) |
|
Details | ||
| 11/11/2024 | IGM Biosciences | IGMS | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2024 | Nkarta Inc. | NKTX | Maintain | Buy (N/A) |
|
Details | ||
| 10/28/2024 | Zymeworks | ZYME | Maintain | Buy (N/A) |
|
Details | ||
| 10/16/2024 | Exelixis | EXEL | Maintain | Hold (N/A) |
|
Details | ||
| 10/14/2024 | Nurix | NRIX | Maintain | Buy (N/A) |
|
Details | ||
| 10/8/2024 | Bicara Therapeutics Inc | BCAX | New Coverage | Buy (N/A) |
25.16 (25.50) |
1.35% | Details | |
| 10/1/2024 | IGM Biosciences | IGMS | Maintain | Buy (Buy) |
|
Details | ||
| 9/10/2024 | Zymeworks | ZYME | Maintain | Buy (Buy) |
|
Details | ||
| 8/7/2024 | MacroGenics | MGNX | Maintain | Hold (N/A) |
|
Details | ||
| 8/2/2024 | Zymeworks | ZYME | Maintain | Buy (N/A) |
|
Details | ||
| 7/12/2024 | Nurix | NRIX | Maintain | Buy (N/A) |
|
Details | ||
| 7/9/2024 | HilleVax, Inc. | HLVX | Downgrade | Hold (Buy) |
14.06 (2.09) |
-85.14% | Details | |
| 6/27/2024 | X4 Pharmaceuticals | XFOR | Maintain | Buy (N/A) |
|
Details | ||
| 6/10/2024 | Geron Corporation | GERN | Maintain | Buy (N/A) |
|
Details | ||
| 5/20/2024 | Compugen | CGEN | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2024 | MacroGenics | MGNX | Downgrade | Hold (Buy) |
14.66 (4.85) |
-66.92% | Details | |
| 4/4/2024 | MacroGenics | MGNX | Maintain | Buy (N/A) |
|
Details | ||
| 3/21/2024 | HilleVax, Inc. | HLVX | Maintain | Buy (N/A) |
|
Details | ||
| 3/21/2024 | Vor Biopharma, Inc. | VOR | Maintain | Buy (N/A) |
|
Details | ||
| 3/8/2024 | MacroGenics | MGNX | Maintain | Buy (N/A) |
|
Details | ||
| 2/14/2024 | Incyte | INCY | Maintain | Hold (N/A) |
|
Details | ||
| 2/2/2024 | Exelixis | EXEL | Maintain | Hold (N/A) |
|
Details | ||
| 11/14/2023 | IGM Biosciences | IGMS | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2023 | Nkarta Inc. | NKTX | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2023 | HilleVax, Inc. | HLVX | Maintain | Buy (N/A) |
|
Details | ||
| 10/16/2023 | Nurix | NRIX | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2023 | IGM Biosciences | IGMS | Maintain | Buy (N/A) |
|
Details | ||
| 8/2/2023 | Incyte | INCY | Maintain | Hold (N/A) |
|
Details | ||
| 8/2/2023 | Exelixis | EXEL | Maintain | Hold (N/A) |
|
Details | ||
| 5/17/2023 | X4 Pharmaceuticals | XFOR | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2023 | IGM Biosciences | IGMS | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2023 | Nkarta Inc. | NKTX | Maintain | Buy (N/A) |
|
Details | ||
| 5/9/2023 | Zymeworks | ZYME | Maintain | Buy (N/A) |
|
Details | ||
| 5/3/2023 | Incyte | INCY | Maintain | Hold (N/A) |
|
Details | ||
| 3/24/2023 | Vor Biopharma, Inc. | VOR | Maintain | Buy (N/A) |
|
Details | ||
| 3/17/2023 | Nkarta Inc. | NKTX | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2023 | Compugen | CGEN | Maintain | Buy (N/A) |
|
Details | ||
| 2/14/2023 | Nurix | NRIX | Maintain | Buy (N/A) |
|
Details | ||
| 2/9/2023 | Exelixis | EXEL | Maintain | Hold (N/A) |
|
Details | ||
| 1/27/2023 | Compass Therapeutics | CMPX | New Coverage | Buy (N/A) |
4.21 (2.08) |
-50.59% | Details | |
| 1/9/2023 | Geron Corporation | GERN | Maintain | Buy (N/A) |
|
Details | ||
| 1/4/2023 | Geron Corporation | GERN | Maintain | Buy (N/A) |
|
Details | ||
| 1/4/2023 | Geron Corporation | GERN | Maintain | Buy (N/A) |
|
Details | ||
| 11/28/2022 | Imago Biosciences Inc | IMGO | Downgrade | Hold (Buy) |
35.66 (36.01) |
0.98% | Details | |
| 11/28/2022 | OmniAb, Inc. | OABI | New Coverage | Buy (N/A) |
2.80 (2.37) |
-15.36% | Details | |
| 11/11/2022 | Vor Biopharma, Inc. | VOR | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2022 | AVEO Pharmaceuticals | AVEO | Downgrade | Hold (Buy) |
14.77 (15.00) |
1.56% | Details | |
| 11/4/2022 | MacroGenics | MGNX | Maintain | Buy (N/A) |
|
Details | ||
| 11/4/2022 | IGM Biosciences | IGMS | Maintain | Buy (N/A) |
|
Details | ||
| 11/2/2022 | Incyte | INCY | Maintain | Hold (N/A) |
|
Details | ||
| 11/2/2022 | Exelixis | EXEL | Maintain | Hold (N/A) |
|
Details | ||
| 10/18/2022 | IGM Biosciences | IGMS | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2022 | MacroGenics | MGNX | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2022 | Compugen | CGEN | Maintain | Hold (N/A) |
|
Details | ||
| 8/3/2022 | Incyte | INCY | Maintain | Hold (N/A) |
|
Details | ||
| 7/22/2022 | X4 Pharmaceuticals | XFOR | Maintain | Buy (N/A) |
|
Details | ||
| 7/8/2022 | Nurix | NRIX | Maintain | Buy (N/A) |
|
Details | ||
| 5/24/2022 | HilleVax, Inc. | HLVX | New Coverage | Buy (N/A) |
10.17 (14.06) |
38.25% | Details | |
| 5/13/2022 | Adagio | ADGI | Maintain | Hold (N/A) |
|
Details | ||
| 5/10/2022 | IGM Biosciences | IGMS | Maintain | Buy (N/A) |
|
Details | ||
| 5/3/2022 | Incyte | INCY | Maintain | Hold (N/A) |
|
Details | ||
| 4/1/2022 | Silverback Therapeutics | SBTX | Downgrade | Hold (Buy) |
3.52 (5.87) |
66.76% | Details | |
| 3/25/2022 | Imago Biosciences Inc | IMGO | Maintain | Buy (N/A) |
|
Details | ||
| 3/18/2022 | Nkarta Inc. | NKTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/17/2022 | SQZ Biotechnologies | SQZ | Maintain | Buy (N/A) |
|
Details | ||
| 3/17/2022 | X4 Pharmaceuticals | XFOR | Maintain | Buy (N/A) |
|
Details | ||
| 3/14/2022 | AVEO Pharmaceuticals | AVEO | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2022 | Zymeworks | ZYME | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2022 | MacroGenics | MGNX | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2022 | Compugen | CGEN | Maintain | Buy (N/A) |
|
Details | ||
| 2/18/2022 | Exelixis | EXEL | Maintain | Hold (N/A) |
|
Details | ||
| 1/28/2022 | Nurix | NRIX | Maintain | Buy (N/A) |
|
Details | ||
| 12/16/2021 | Adagio | ADGI | Maintain | Hold (N/A) |
|
Details | ||
| 12/15/2021 | Adagio | ADGI | Downgrade | Hold (Buy) |
34.26 (4.64) |
-86.46% | Details | |
| 12/13/2021 | IGM Biosciences | IGMS | Maintain | Buy (N/A) |
|
Details | ||
| 11/11/2021 | Silverback Therapeutics | SBTX | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2021 | Seagen | SGEN | Maintain | Hold (N/A) |
|
Details | ||
| 11/9/2021 | AVEO Pharmaceuticals | AVEO | Maintain | Buy (N/A) |
|
Details | ||
| 8/31/2021 | Adagio | ADGI | New Coverage | Buy (N/A) |
30.38 (4.64) |
-84.73% | Details | |
| 8/13/2021 | Nkarta Inc. | NKTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/10/2021 | Imago Biosciences Inc | IMGO | New Coverage | Buy (N/A) |
24.49 (36.01) |
47.04% | Details | |
| 8/6/2021 | Exelixis | EXEL | Maintain | Hold (N/A) |
|
Details | ||
| 7/30/2021 | Seagen | SGEN | Maintain | Hold (N/A) |
|
Details | ||
| 7/30/2021 | MacroGenics | MGNX | Maintain | Buy (N/A) |
|
Details | ||
| 7/29/2021 | Compugen | CGEN | Maintain | Buy (N/A) |
|
Details | ||
| 5/14/2021 | Silverback Therapeutics | SBTX | Maintain | Buy (N/A) |
|
Details | ||
| 5/14/2021 | Nkarta Inc. | NKTX | Maintain | Buy (N/A) |
|
Details | ||
| 5/14/2021 | Molecular Templates | MTEM | Maintain | Buy (N/A) |
|
Details | ||
| 5/11/2021 | AVEO Pharmaceuticals | AVEO | Maintain | Buy (N/A) |
|
Details | ||
| 4/30/2021 | Seagen | SGEN | Maintain | Hold (N/A) |
|
Details | ||
| 4/30/2021 | MacroGenics | MGNX | Maintain | Buy (N/A) |
|
Details | ||
| 4/14/2021 | Nurix | NRIX | Maintain | Buy (N/A) |
|
Details | ||
| 3/30/2021 | Silverback Therapeutics | SBTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/26/2021 | Nkarta Inc. | NKTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/19/2021 | SQZ Biotechnologies | SQZ | Maintain | Buy (N/A) |
|
Details | ||
| 3/19/2021 | Molecular Templates | MTEM | Maintain | Buy (N/A) |
|
Details | ||
| 3/11/2021 | AVEO Pharmaceuticals | AVEO | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2021 | Compugen | CGEN | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2021 | Zymeworks | ZYME | Maintain | Buy (N/A) |
|
Details | ||
| 2/17/2021 | Nurix | NRIX | Maintain | Buy (N/A) |
|
Details | ||
| 2/12/2021 | Seagen | SGEN | Maintain | Hold (N/A) |
|
Details | ||
| 12/29/2020 | Silverback Therapeutics | SBTX | New Coverage | Buy (N/A) |
35.77 (5.87) |
-83.59% | Details | |
| 12/21/2020 | Nurix | NRIX | Maintain | Buy (N/A) |
|
Details | ||
| 12/21/2020 | Nkarta Inc. | NKTX | Maintain | Buy (N/A) |
|
Details | ||
| 11/24/2020 | SQZ Biotechnologies | SQZ | New Coverage | Buy (N/A) |
27.62 (0.44) |
-98.41% | Details | |
| 11/9/2020 | AVEO Pharmaceuticals | AVEO | New Coverage | Buy (N/A) |
5.83 (15.00) |
157.29% | Details | |
| 10/26/2020 | Exelixis | EXEL | Maintain | Hold (N/A) |
|
Details | ||
| 9/22/2020 | Seattle Genetics | SGEN | Maintain | Hold (N/A) |
|
Details | ||
| 8/18/2020 | Nurix | NRIX | New Coverage | Buy (N/A) |
23.88 (19.71) |
-17.46% | Details | |
| 8/11/2020 | Inovio Pharmaceuticals | INO | Maintain | Hold (N/A) |
|
Details | ||
| 8/7/2020 | Molecular Templates | MTEM | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2020 | Nkarta Inc. | NKTX | New Coverage | Buy (N/A) |
25.75 (3.04) |
-88.19% | Details | |
| 8/3/2020 | Geron Corporation | GERN | New Coverage | Buy (N/A) |
1.68 (1.39) |
-17.26% | Details | |
| 7/31/2020 | MacroGenics | MGNX | Maintain | Buy (N/A) |
|
Details | ||
| 7/31/2020 | Seattle Genetics | SGEN | Maintain | Hold (N/A) |
|
Details | ||
| 6/30/2020 | IGM Biosciences | IGMS | Maintain | Buy (N/A) |
|
Details | ||
| 6/26/2020 | Inovio Pharmaceuticals | INO | Downgrade | Hold (Buy) |
23.87 (1.15) |
-95.18% | Details | |
| 5/29/2020 | MacroGenics | MGNX | Maintain | Buy (Buy) |
|
Details | ||
| 5/13/2020 | Compugen | CGEN | New Coverage | Buy (N/A) |
15.58 (2.01) |
-87.1% | Details | |
| 5/8/2020 | IGM Biosciences | IGMS | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2020 | Exelixis | EXEL | Maintain | Hold (N/A) |
|
Details | ||
| 5/6/2020 | MacroGenics | MGNX | Maintain | Buy (N/A) |
|
Details | ||
| 5/1/2020 | Seattle Genetics | SGEN | Maintain | Hold (N/A) |
|
Details | ||
| 4/29/2020 | Inovio Pharmaceuticals | INO | Maintain | Buy (N/A) |
|
Details | ||
| 4/20/2020 | Seattle Genetics | SGEN | Maintain | Hold (N/A) |
|
Details | ||
| 3/27/2020 | IGM Biosciences | IGMS | Maintain | Buy (N/A) |
|
Details | ||
| 3/25/2020 | Molecular Templates | MTEM | New Coverage | Buy (N/A) |
12.33 (0.11) |
-99.11% | Details | |
| 3/17/2020 | Spero Therapeutics | SPRO | Maintain | Buy (N/A) |
|
Details | ||
| 3/13/2020 | Inovio Pharmaceuticals | INO | Maintain | Buy (N/A) |
|
Details | ||
| 3/12/2020 | Atreca Inc. | BCEL | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2020 | Inovio Pharmaceuticals | INO | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2020 | Dicerna Pharmaceuticals | DRNA | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2020 | MacroGenics | MGNX | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2020 | Exelixis | EXEL | Maintain | Hold (N/A) |
|
Details | ||
| 2/3/2020 | IGM Biosciences | IGMS | Maintain | Buy (N/A) |
|
Details | ||
| 2/3/2020 | Zymeworks | ZYME | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2019 | Dicerna Pharmaceuticals | DRNA | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2019 | Ra Pharma | RARX | Downgrade | Hold (Buy) |
46.90 (48.00) |
2.35% | Details | |
| 10/14/2019 | IGM Biosciences | IGMS | New Coverage | Buy (N/A) |
17.25 (1.27) |
-92.64% | Details | |
| 9/30/2019 | Seattle Genetics | SGEN | Maintain | Buy (N/A) |
|
Details | ||
| 8/30/2019 | Zymeworks | ZYME | New Coverage | Buy (N/A) |
26.50 (24.41) |
-7.89% | Details | |
| 8/5/2019 | Glycomimetics | GLYC | Maintain | Buy (N/A) |
|
Details | ||
| 7/29/2019 | Lexicon Pharmaceuticals | LXRX | Downgrade | Hold (N/A) |
5.61 (2.25) |
-59.89% | Details | |
| 7/15/2019 | Atreca Inc. | BCEL | New Coverage | Buy (N/A) |
16.74 (0.09) |
-99.46% | Details | |
| 6/17/2019 | Incyte | INCY | Maintain | Hold (N/A) |
|
Details | ||
| 6/7/2019 | X4 Pharmaceuticals | XFOR | New Coverage | Buy (N/A) |
14.11 (3.25) |
-76.97% | Details | |
| 5/22/2019 | Array BioPharma | ARRY | Maintain | Buy (N/A) |
|
Details | ||
| 5/21/2019 | Array BioPharma | ARRY | Maintain | Buy (N/A) |
|
Details | ||
| 4/26/2019 | Seattle Genetics | SGEN | Maintain | Hold (N/A) |
|
Details | ||
| 4/11/2019 | Seattle Genetics | SGEN | New Coverage | Hold (N/A) |
79.40 (228.74) |
188.09% | Details | |
| 4/11/2019 | Incyte | INCY | New Coverage | Hold (N/A) |
82.73 (69.22) |
-16.33% | Details | |
| 4/10/2019 | Ra Pharma | RARX | Maintain | Buy (Buy) |
|
Details | ||
| 3/25/2019 | Lexicon Pharmaceuticals | LXRX | Maintain | Buy (N/A) |
|
Details | ||
| 3/14/2019 | Proteon Therapeutics | PRTO | Maintain | Hold (N/A) |
|
Details | ||
| 3/13/2019 | Inovio Pharmaceuticals | INO | Maintain | Buy (N/A) |
|
Details | ||
| 3/5/2019 | Chimerix | CMRX | Maintain | Hold (N/A) |
|
Details | ||
| 2/27/2019 | Spark Therapeutics | ONCE | Downgrade | Hold (Buy) |
113.48 (110.05) |
-3.02% | Details | |
| 2/20/2019 | Spark Therapeutics | ONCE | Maintain | Buy (N/A) |
|
Details | ||
| 2/8/2019 | Ra Pharma | RARX | New Coverage | Buy (N/A) |
20.82 (46.90) |
125.26% | Details | |
| 2/5/2019 | Array BioPharma | ARRY | Maintain | Buy (N/A) |
|
Details | ||
| 12/6/2018 | Conatus Pharmaceuticals | CNAT | Downgrade | Hold (Buy) |
4.50 (0.56) |
-87.56% | Details | |
| 11/9/2018 | Achaogen | AKAO | Downgrade | Hold (Buy) |
3.08 (0.11) |
-96.43% | Details | |
| 11/6/2018 | Spark Therapeutics | ONCE | Maintain | Buy (N/A) |
|
Details | ||
| 11/1/2018 | Lexicon Pharmaceuticals | LXRX | Maintain | Buy (N/A) |
|
Details | ||
| 10/2/2018 | Inovio Pharmaceuticals | INO | New Coverage | Buy (N/A) |
5.56 (1.15) |
-79.32% | Details | |
| 9/17/2018 | Loxo Oncology | LOXO | Maintain | Buy (N/A) |
|
Details |
